Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 401661 - 401680 out of 495680 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Slovakia | (L01FA03) obinutuzumab | Gazyvaro 1 000 mg infúzny koncentrát | con inf 1x40 ml (liek inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheRegistrationGmbH |
| Slovakia | (L01FB01) inotuzumab ozogamicin | BESPONSA 1 mg prášok na infúzny koncentrát | plc ifc 1x1 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerEuropeMAEEIG |
| Slovakia | (L01FC01) daratumumab | DARZALEX 20 mg/ml infúzny koncentrát | con inf 1x20 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V. |
| Slovakia | (L01FC01) daratumumab | DARZALEX 20 mg/ml infúzny koncentrát | con inf 1x5 ml/100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V. |
| Slovakia | (L01FD01) trastuzumab | Herceptin 600 mg injekčný roztok v liekovke | sol inj 1x5 ml (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | RocheRegistrationGmbH |
| Slovakia | (L01FD01) trastuzumab | KANJINTI 150 mg prášok na infúzny koncentrát | plc ifc 1x150 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenEuropeB.V. |
| Slovakia | (L01FD01) trastuzumab | Ogivri 150 mg prášok na infúzny koncentrát | plc ifc 1x150 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BiosimilarCollaborationsIrelandLimited |
| Slovakia | (L01FD01) trastuzumab | Trazimera 150 mg prášok na infúzny koncentrát | plc ifc 1x150 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerEuropeMAEEIG |
| Slovakia | (L01FD01) trastuzumab | Zercepac 150 mg prášok na infúzny koncentrát | plc ifc 1x150 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U |
| Slovakia | (L01FD02) pertuzumab | Perjeta 420 mg infúzny koncentrát | con inf 1x420 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Slovakia | (L01FD03) trastuzumab emtansine | Kadcyla 100 mg prášok na infúzny koncentrát | plc ifc 1x100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Slovakia | (L01FD03) trastuzumab emtansine | Kadcyla 160 mg prášok na infúzny koncentrát | plc ifc 1x160 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Slovakia | (L01FE01) cetuximab | Erbitux 5 mg/ml infúzny roztok | sol inf 1x20 ml/100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MerckEuropeB.V. |
| Slovakia | (L01FE02) panitumumab | Vectibix 20 mg/ml infúzny koncentrát | con inf 1x20 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. |
| Slovakia | (L01FE02) panitumumab | Vectibix 20 mg/ml infúzny koncentrát | con inf 1x5 ml/100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. |
| Slovakia | (L01FF01) nivolumab | OPDIVO 10 mg/ml infúzny koncentrát | con inf 1x4 ml/40 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Slovakia | (L01FF04) avelumab | Bavencio 20 mg/ml infúzny koncentrát | con inf 1x10 ml/200 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckEuropeB.V. |
| Slovakia | (L01FG01) bevacizumab | Abevmy 25 mg/ml koncentrát na infúzny roztok | con inf 1x16 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | BiosimilarCollaborationsIrelandLimited |
| Slovakia | (L01FG01) bevacizumab | Abevmy 25 mg/ml koncentrát na infúzny roztok | con inf 1x4 ml/100 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | BiosimilarCollaborationsIrelandLimited |
| Slovakia | (L01FG01) bevacizumab | Alymsys 25 mg/ml koncentrát na infúzny roztok | con inf 1x16 ml/400 mg (liek.inj.skl.) | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | MabxienceResearchSL |
Pages
